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The deadly neurotoxins of Clostridium botulinum (BoNTs) comprise eight
serotypes (A–G; X). The neurotoxin gene cluster encoding BoNT and its
accessory proteins includes an operon containing an ntnh gene upstream of
the boNT gene. Another operon contains either ha (haemagglutinin) or orfX
genes (of unknown function). Here we describe a novel boNT gene cluster
from Enterococcus sp. 3G1_DIV0629, with a typical ntnh gene and an
uncommon orfX arrangement. The neurotoxin (designated putative eBoNT/J)
contains a metallopeptidase zinc-binding site, a translocation domain and a
target cell attachment domain. Structural properties of the latter suggest a
novel targeting mechanism with consequent implications for application by
the pharmaceutical industry. This is the first complete boNT gene cluster
identified in a non-clostridial genome.
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Neurotoxins produced by Clostridium botulinum and
occasional strains of C. baratii and C. butyricum
(BoNTs) cause a severe and fatal neuro-paralytic dis-
ease of humans and animals (botulism) [1]. Currently
there are eight recognised serotypes of the BoNT pro-
tein (A–G, and recently X [2,3]). Biologically active
BoNT is complexed with several accessory proteins, all
encoded by a neurotoxin gene cluster. This gene clus-
ter is often associated with mobile elements or is
located on a plasmid or bacteriophage, indicating that
it is capable of horizontal gene transfer between bacte-
ria sharing a common environment [4]. The gene for
the coexpressed protein NTNH is always located
upstream of the gene that encodes BoNT. A further
operon encodes typically three genes that fall into two
categories; ha genes (haemagglutinin) and orfX genes
(of unknown function) [2]. Accessory gene products
are needed to ensure survival of the BoNT toxin com-
plex during its passage through the gastrointestinal
tract, and for transfer through the gut wall into the
circulatory system with subsequent delivery to the tar-
get nerve cell, although the exact mechanism for
translocation across the gut epithelium has only been
shown for the HA proteins [2,5]. BoNT is the most
potent toxin known [1]. It is a zinc metallopeptidase
with an extreme specificity for its target, the SNARE
docking proteins of cholinergic nerve cells. BoNT
activity destroys the function of these SNAREs, pre-
venting exocytosis of the neurotransmitter acetyl-
choline with subsequent floppy paralysis of associated
muscle tissue [6]. BoNT is used both in the cosmetic
and pharmaceutical industries. As such, there is great
interest in the discovery of new forms of BoNT, in the
hope that these will increase the range of medical con-
ditions that can be alleviated.
Here we describe the discovery of a novel boNT
gene cluster that exists not in the C. botulinum,
C. baratii or C. butyricum genome but within the gen-
ome of a species of Enterococcus. The Enterococcus sp.
3G1_DIV0629 genome contains a botulinum-like
Abbreviations
GI, genomic island; HA, haemagglutinin; NCBI, National Center for Biotechnology Information; wgMLST, whole genome multilocus
sequence typing; WGS, whole genome sequence.
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neurotoxin gene cluster with a typical ntnh gene and
an uncommon orfX arrangement. The predicted neuro-
toxin gene product from this cluster (designated herein
putative eBoNT/J) contains all the functional domains
characteristic of a typical neurotoxin, including a met-
allopeptidase zinc-binding site, a translocation domain
and a target cell attachment domain [7]. Structural
properties of the latter domain suggest a novel target-
ing mechanism with consequent implications for appli-
cation by the pharmaceutical industry. This the first
report of a complete new botulinum-like neurotoxin
gene cluster outside of the Clostridium species.
Methods
Putative eBoNT/J was identified using known BoNT protein
sequences to search the whole genome sequence (WGS)
database (visited October 2017) at the National Center for
Biotechnology Information (NCBI). An unrooted Neigh-
borNet phylogenetic network of clostridial neurotoxin pro-
teins was computed using the SplitsTree4 application [8].
Parameters used for preliminary sequence alignment in Gen-
eious [9] using CLUSTALW were: cost matrix blosum; gap open
cost 10; gap extend cost 0.1. The programme SIMPLOT [10]
from the DAMBE software suite [11] was used to compare
putative eBoNT/J and its associated NTNH with represen-
tative examples of other neurotoxin amino acid sequences;
we performed this analysis to identify possible mosaic
sequences. Parameters used were: window size 100, step
length 20, genetic distance PoissonP, using either putative
eBoNT/J or NTNH as seed. An iterative search method
(JACKHMMER) was used to compare the predicted gene
product of putative eBoNT/J with reference proteomes of
C. botulinum until convergence. Functional protein domains
were identified using HMMER [12] and Pfam [13].
To determine the closest relative of strain Enterococcus
sp. 3G1_DIV0629, we used the web-based tool PGAdb-
builder, which uses a pipeline based on whole genome mul-
tilocus sequence typing (wgMLST; [14]). Genome sequences
were downloaded in FASTA file format as contigs or com-
plete genome sequences from the NCBI website. For phylo-
genetic analysis, representative enterococcal genome
sequences [15] were reannotated using Prokka [16], and
comparative genomics performed using Roary [17]. The
phylogenetic tree was produced (UPGMA) with the PHYLIP
programme using the constructed allelic sequences and
bootstrap values calculated by the ETE tool [18]. DNA
G + C content of complete genomes was taken from the
appropriate NCBI Genome Assembly and Annotation
report pages. ISLANDVIEWER 4 [19] was used for identifica-
tion and visualisation of genomic islands (GIs).
The amino acid sequence of putative eBoNT/J was
further analysed using the programme Phyre2 [20], which
predicts 3D protein structure. Further analysis and
comparison of putative eBoNT/J toxin and its associated
NTNH to BoNT/A and BoNT/A complexed with its
NTNH was performed by using the I-Tasser simulation
[21] which selects the best structural model that fits the
query sequence. Estimated accuracy of the predicted model
using I-TASSER was; TM score 0.86  0.07, C-score = 1.07
and RMSD = 7.0  4.1 A (eBoNT/J) and TM score
0.87  0.07, C-score = 1.17 and RMSD = 6.6  4.0 A
(NTNH).
Results and Discussion
A bioinformatics search of the WGS database (visited
October 2017) at the NCBI, using the predicted
protein translation product of boNT genes scored a hit
with the product of a gene from a recently deposited
(Earl A. et al. May 2017) genome of Enterococcus
sp. 3G1_DIV0629 (NCBI accession number NGLI01
000004.1; this refers to contig 4 from the sequencing
assembly). The Enterococcus putative neurotoxin gene
product shared 39% identical residues with its closest
relative, BoNT/X, with 58% residues exhibiting conser-
vative changes. The contig containing the boNT-like gene
was further examined, to reveal a set of genes upstream
that were similar to the orfX1, orfX2, orfX3, p47 and
ntnh genes of other orfX-type boNT neurotoxin gene
clusters [2,3] although distantly related (26–36% amino
acid sequence to closest relative, BoNT/X). In all other
examples of orfX neurotoxin gene clusters, only the p47
gene respects the direction of expression of ntnh and
boNT, with the three orfX genes facing in the opposite
direction (Fig. 1). Although the recently discovered
botulinum neurotoxin homologue in Weissella oryzae
SG25 [22] has been tentatively named boNT/Wo [23],
until neurotoxicity studies have been performed, we pro-
pose to call this new homologue putative eboNT/J. As
with many boNT gene clusters, that of putative eBoNT/J
is bordered by IS elements [2,24], evidence that it may
have been acquired by horizontal gene transfer (Fig. 1).
A NeighborNet phylogenetic network of clostridial
neurotoxin proteins (including the putative neurotoxin
of W. oryzae SG25) was estimated using the SPLITSTREE
programme. The output can be compared directly with
that used to demonstrate the discovery of BoNT/X [3].
Predicted gene products of the adjacent ntnh gene were
similarly analysed (Fig. 2A,B). As shown by the posi-
tion and length of their branchpoint, putative eBoNT/
J is most closely related (38% identity) to BoNT/X,
and all other neurotoxins are equally distant (23–25%
identity), apart from the putative neurotoxin of Wei-
sella which shares the least protein identity (13%). A
similar result was obtained with the putative eBoNT/J
NTNH protein.
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An iterative search (JACKHMMER) was used to
compare the predicted gene product of putative
eBoNT/J with reference proteomes of C. botulinum
until convergence. The resulting 232 matches to botuli-
num toxin showed that putative eBoNT/J possesses all
domains known to be required for BoNT activity; fur-
thermore, these are located in their correct positions
[7] (Fig. 2C). These include a light chain containing
the zinc binding site of an M27 peptidase (HELCH)
at positions 225–229 [25], cysteine residues at positions
424 and 438 required for the disulphide bridge
between heavy and light chains following proteolytic
cleavage and activation [7] (putative eBoNT/J lacks
the extra C residue in this linker region that is present
in BoNT/X), a translocation domain (residues 529–
843) at the N terminus of the heavy chain containing
a version (PYLGNIL, residues 622–628; in BoNT/X
this is PYIGPLL) of the conserved PYxGxAL motif
required for toxin translocation from the endosome
into the target nerve cell cytoplasm [26] and N and C
termini (HCN, HCC) of the C-terminal-binding domain
of the heavy chain that are required for binding to the
target cell and initiation of endocytosis. With BoNT/
A, B, E, F and G, this appropriation of the normal
host synaptic vesicle recycling pathways involves a
dual host–receptor mechanism comprising a synaptic
vesicle protein and a ganglioside [27–31]. These
BoNT–ganglioside interactions are facilitated by a
SxWY motif located in the C terminus of the heavy
chain binding domain; in putative eBoNT/J, this motif
is SAWY (residues 1250–1253) and is identical to that
of BoNT/X.
Similarity plots were used to further analyse putative
eBoNT/J and its accompanying NTNH for relatedness
to other BoNT and NTNH proteins (Fig. 2C,D). As
indicated by SplitsTree, BoNT/X remained the closest
relative throughout its entire length (Fig. 2C); how-
ever, all NTNH sequences seemed to be approximately
equally distant from that of putative eBoNT/J
(Fig. 2D), except for the NTNH-like peptide associ-
ated with the putative neurotoxin of Weisella which is
a clear outlier.
The amino acid sequence of putative eBoNT/J was
further analysed using the programme Phyre2 [20],
which predicts 3D protein structure. This predicted a
protein structure for putative eBoNT/J that exactly
matched a BoNT with a 100% confidence limit. This
shows that not only does the entire length of putative
eBoNT/J share amino acid sequence conservation with
other BoNTs but it also shares structural identity.
Another modelling programme, I-TASSER showed
that the predicted structure for putative eBoNT/J most
closely matched that of a BoNT/A molecule; this
match was also mirrored when the NTNH associated
with eBoNT/J was superimposed with the structure
determined for BoNT/A complexed with its own
NTNH, suggesting that if expressed, the putative
eBoNT/J could form a similar complex (Fig. 3).
Electron microscopy studies of progenitor BoNT/A
complex have shown that its NTNH moiety carries the
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Fig. 1. Neurotoxin gene clusters of (A) Enterococcus sp. 3G1_DIV0629; (B1) C. botulinum Group I ha types A, B; C. botulinum Group II type
B; C. botulinum Group III (*Group III neurotoxin gene clusters position the gene for transcription factor botR upstream of ha70); C.
botulinum Group IV (the type G neurotoxin gene cluster swaps the positions of ha70 and ha34). (B2) Group I orf-X types A, F († Group I
neurotoxin gene clusters include botR at this position); Group II types E, F. (B3) boNT/X. (B4) Weissella oryzae SG25. Purple regions in ntnh-
like refer to Big 3 domains that are not present in the ntnh-like gene. Note that the putative Weisella neurotoxin gene is not associated with
ntnh, ha or orfx accessory genes.
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Fig. 2. (A,B) SplitsTree plots of BoNT and NTNH protein sequences respectively. TeNT protein is not associated with an NTNH accessory
protein. Both plots show that BoNT/X and eBoNT/J and their associated NTNH are more closely related to each other than they are to all
other proteins. (C,D). SimPlot analyses of BoNT and NTNH protein domain sequences, respectively, using eBoNT/J and its NTNH as seeds;
main functional domains of each eBoNT/J cluster protein are outlined above. The closer relatedness of BoNT/X to eBoNT/J continues
throughout its length; however, the NTNH associated with eBoNT/J is almost equally distant from all other examples.
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binding site for HA70, occupied during formation of
the active botulinum toxin complex. This binding site
is conserved in other BoNTs that form complexes with
HA moieties. Those BoNTs that derive from an orf-X
neurotoxin gene cluster lack this site, which has been
located to a 33-residue region located ~ 120 residues
from the N terminus, termed the nLoop [32,33]. Both
BoNT/X and putative eBoNT/J share this deletion,
which is evidence that they have evolved alongside
their Orf-X accessory proteins.
Species of Enterococcus are Gram-positive bacteria
of the phylum Firmicutes, order Lactobacillales that
can be commensal in the gastrointestinal tract of
humans and animals, but may also be pathogenic,
causing diseases such as neonatal meningitis or endo-
carditis [34]. Enterococcus sp. 3G1_DIV0629 was iso-
lated from cow faeces in South Carolina, USA. It is
distinct from currently recognised species, so has not
yet been given a specific name (see NCBI project num-
ber PRJNA313452). To determine the closest relative
of this strain, we used wgMLST to establish that Ente-
rococcus sp. 3G1_DIV0629 was most closely related to
the probiotic strain Enterococcus faecium T-110 [35],
(Fig. 4). A search of all publicly available (> 1000)
Enterococcus genomes failed to identify another strain
containing a botulinum neurotoxin gene cluster.
To determine whether the putative eboNT/J neuro-
toxin gene cluster has been acquired via horizontal
gene transfer, its DNA G + C content was analysed.
The G + C content of all sequenced genomes of
E. faecium ranges between 36.7% and 42.8%; that of
a group of 77 uncharacterised isolates of Enterococcus
(of which strain 3G1_DIV0629 is a member) is 33.1–
43.3%. The average G + C content of the Enterococ-
cus sp. 3G1_DIV0629 genome is 37.2%, which falls
within these ranges. However, contig 4, which contains
the putative eboNT/J neurotoxin gene cluster has an
unusually low G + C content (31.8% as compared to
38.0–39.3% for the other main (> 50 kb) contigs).
That for a 20 kb region of contig 4 encompassing the
putative eboNT/J neurotoxin gene cluster, including
the IS elements upstream and downstream, was
31.8%, which is identical to the rest of the same con-
tig. Using the DNA sequence of contig 4 as a query,
the NCBI WGS database of all sequenced members of
phylum Firmicutes was interrogated. All regions of
contig 4 which generated a match (~ 30%) were to
enterococcal plasmid sequences; particularly to an
~ 52 kb region in the centre of the contig, mapping
immediately upstream of the neurotoxin gene cluster.
However, isolated matches to enterococcal plasmid
sequences were scattered throughout contig 4. Consid-
ering that the size of contig 4 matches that of several
examples of enterococcal plasmids, it is possible that
this entire contig represents a plasmid sequence. How-
ever, it is equally possible that contig 4 represents a
horizontally acquired GI, the G + C content of which
is often typically lower than that of its host genome
[36]. Using ISLANDVIEWER 4, a software programme for
identification and visualisation of GIs [19], a compar-
ison between Enterococcus sp. 3G1_DIV0629 and its
closest relative E. faecium T-110 shows that the
A B
SAWY
HELCH
Fig 3. Structure prediction and comparison of putative eBoNT/J toxin and its associated NTNH to BoNT/A and BoNT/A complexed with its
NTNH, respectively.(A) Superposition of the predicted structure of putative eBoNT/J (gold) with the crystal structure of an inactive BoNT/A
(blue Protein Data bank ID: 3V0C). Positions of the zinc-binding site (HELCH) and target cell-binding motif (SAWY) are indicated by green
ovals. (B) Superposition of the predicted structure of the eBoNT/J NTNH (gold) with that determined for BoNT/A (red) complexed with its
own NTNH (blue; Protein Data bank ID: 3V0B).
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putative eboNT/J toxin gene cluster lies between two
predicted pathogenicity islands (a type of GI); how-
ever, comparison of the G + C plot of this region with
that of the entire chromosome of strain T-110 indi-
cates that the entire contig may be a GI (data not
shown). More sequencing work is needed to confirm
this speculation, as the insertion sites for GIs are often
found at the switch sites of GC-skew [37]. The DNA
G + C content of 203 sequenced C. botulinum genomes
in the NCBI genome database exhibits a narrow range
of 27.0–29.8%, somewhat lower than that for Entero-
coccus. This probably reflects the fact that the last
common ancestor of the Lactobacillales and the
Clostridiales existed ~ 2.8 billion years ago [38] and
suggests that if the putative eboNT/J neurotoxin gene
cluster has been acquired horizontally (as suggested by
the presence of the two IS elements, Fig. 1), then the
donor organism may not be C. botulinum.
Conclusion
In summary, this work reports the bioinformatic dis-
covery of the first complete boNT toxin gene cluster
located in a non-clostridial genome. The organisation
and sequence identity of this gene cluster shows that
its closest relative is the recently published boNT/X
cluster from C. botulinum strain 111. Although amino
acid sequence homology with BoNT/X is only 38%,
3D structure modelling shows that putative eBoNT/J
closely mimics the structure of the most potent neuro-
toxin, BoNT/A. Significantly, as with BoNT/X, varia-
tion in the relevant region of the C terminus of the
heavy chain indicates that it may possess a novel cell-
binding domain. Further work will be required to
investigate whether this structural variation will have
important implications for the potential use of putative
eBoNT/J as a therapeutic agent. Finally, as this work
is purely a bioinformatics study, with no access to the
bacterial strain, there is no information available
regarding whether the putative eboNT/J toxin gene
cluster is expressed by its host. However, the fact that
all open reading frames for the putative toxin cluster
genes are intact strongly suggests that expression is
likely. Associated metadata with the genome sequence
do not indicate that the herd from which the faecal
sample was taken had suffered from symptoms of
Fig 4. Phylogenetic tree of Enterococcus, showing close relatedness of Enterococcus sp 3G1_DIV0629 to E. faecium T110.
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botulism. Both questions are intriguing and will be the
subject of future work.
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